UnknownEarly Phase 1NCT04951141

Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors

Studying Cholangiocarcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Beijing Immunochina Medical Science & Technology Co., Ltd.
Principal Investigator
Yin ying Lu, M.D.
Beijing 302 Hospital
Intervention
anti-GPC3 CAR-T cells(biological)
Enrollment
10 enrolled
Eligibility
18-69 years · All sexes
Timeline
2019 – 2023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04951141 on ClinicalTrials.gov

Other trials for Cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Cholangiocarcinoma →

← Back to all trials